INSULIN IMMUNIZATION OF NONOBESE DIABETIC MICE INDUCES A PROTECTIVE INSULITIS CHARACTERIZED BY DIMINISHED INTRAISLET INTERFERON-GAMMA TRANSCRIPTION

被引:250
作者
MUIR, A
PECK, A
CLARESALZLER, M
SONG, YH
CORNELIUS, J
LUCHETTA, R
KRISCHER, J
MACLAREN, N
机构
[1] UNIV FLORIDA, COLL MED, DEPT PATHOL & LAB MED, DIV IMMUNOL, GAINESVILLE, FL 32610 USA
[2] UNIV FLORIDA, COLL MED, DEPT PEDIAT, GAINESVILLE, FL 32610 USA
[3] UNIV S FLORIDA, H LEE MOFFITT CANC CTR, TAMPA, FL 32612 USA
关键词
DIABETES; IMMUNOREGULATION; B-CHAIN; ADJUVANT; THERAPY;
D O I
10.1172/JCI117707
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We reported previously that daily injections of isophane insulin prevented both hyperglycemia and insulitis in nonobese diabetic (NOD) mice (Atkinson, M., N. Maclaren; and R. Luchetta. 1990. Diabetes. 39:933-937). The possible mechanisms responsible include reduced immunogenicity of pancreatic beta-cells from ''beta-cell rest'' and induced active immunoregulation to insulin (Aaen, K., J. Rygaard, K. Josefsen, H. Petersen, C. H. Brogren, T. Horn, and K. Buschard. 1990. Diabetes. 39:697-701). We report here that intermittent immunizations with insulin or its metabolically inactive B-chain in incomplete Freund's adjuvant also prevent diabetes in NOD mice, whereas immunizations with A-chain insulin or with BSA do not. Adoptive transfer of splenocytes from B-chain insulin-immunized mice prevented diabetes in recipients co-infused with diabetogenic spleen cells, an effect that was abolished by prior in vivo elimination of either CD4+ or CD8+ cells. Insulin immunization did not reduce the extent of intraislet inflammation (insulitis); however, it did abolish expression of IFN-gamma mRNA within the insulitis lesions. Immunizations with insulin thus induce an active suppressive response to determinants on the B-chain that converts the insulitis lesion from one that is destructive to one that is protective.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 40 条
[1]   DEPENDENCE OF ANTIGEN EXPRESSION ON FUNCTIONAL-STATE OF BETA-CELLS [J].
AAEN, K ;
RYGAARD, J ;
JOSEFSEN, K ;
PETERSEN, H ;
BROGREN, CH ;
HORN, T ;
BUSCHARD, K .
DIABETES, 1990, 39 (06) :697-701
[2]   NEW PERSPECTIVES ON IMMUNOINTERVENTION IN AUTOIMMUNE-DISEASES [J].
ADORINI, L ;
BARNABA, V ;
BONA, C ;
CELADA, F ;
LANZAVECCHIA, A ;
SERCARZ, E ;
SUCIUFOCA, N ;
WEKERLE, H .
IMMUNOLOGY TODAY, 1990, 11 (11) :383-386
[3]   INSULIN-DEPENDENT DIABETES IN THE NOD MOUSE MODEL .2. BETA-CELL DESTRUCTION IN AUTOIMMUNE DIABETES IS A TH2 AND NOT A TH1 MEDIATED EVENT [J].
ANDERSON, JT ;
CORNELIUS, JG ;
JARPE, AJ ;
WINTER, WE ;
PECK, AB .
AUTOIMMUNITY, 1993, 15 (02) :113-122
[4]   ISLET-CELL AUTOANTIGENS IN INSULIN-DEPENDENT DIABETES [J].
ATKINSON, MA ;
MACLAREN, NK .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1608-1616
[5]   INSULITIS AND DIABETES IN NOD MICE REDUCED BY PROPHYLACTIC INSULIN THERAPY [J].
ATKINSON, MA ;
MACLAREN, NK ;
LUCHETTA, R .
DIABETES, 1990, 39 (08) :933-937
[6]   MODULATION OF BETA-CELL ACTIVITY AND ITS INFLUENCE ON ISLET-CELL ANTIBODY (ICA) AND ISLET-CELL SURFACE ANTIBODY (ICSA) REACTIVITY [J].
BJORK, E ;
KAMPE, O ;
GRAWE, J ;
HALLBERG, A ;
NORHEIM, I ;
KARLSSON, FA .
AUTOIMMUNITY, 1993, 16 (03) :181-188
[7]   T-CELL-MEDIATED INHIBITION OF THE TRANSFER OF AUTOIMMUNE DIABETES IN NOD MICE [J].
BOITARD, C ;
YASUNAMI, R ;
DARDENNE, M ;
BACH, JF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1669-1680
[8]  
CAMPBELL IL, 1988, J IMMUNOL, V141, P2325
[9]   ESSENTIAL ROLE FOR INTERFERON-GAMMA AND INTERLEUKIN-6 IN AUTOIMMUNE INSULIN-DEPENDENT DIABETES IN NOD/WEHI MICE [J].
CAMPBELL, IL ;
KAY, TWH ;
OXBROW, L ;
HARRISON, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :739-742
[10]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551